Question 1

What is AstraZeneca's P/E ratio?

Accepted Answer

AstraZeneca (AZN) P/E ratio is 27.9× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month earnings (net income), using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/E ratio calculated?

Accepted Answer

P/E = Share Price ÷ Trailing Twelve-Month (TTM) Diluted EPS, or equivalently Market Capitalisation ÷ TTM Net Income. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/E ratio?

Accepted Answer

The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.

Question 4

What is a good P/E ratio for AstraZeneca?

Accepted Answer

There is no universal "good" P/E. As a rule of thumb, the S&P 500 has historically averaged a P/E in the mid-to-high teens; mature, slow-growth businesses commonly trade in the 10–18× range, while high-growth or asset-light companies often trade at 25–50×+. What matters is the comparison to sector peers and to the company's own historical range. For AstraZeneca specifically, the relevant sector benchmark is the current sector median of 25.0×.

Question 5

Is AstraZeneca's P/E ratio high or low?

Accepted Answer

AstraZeneca's P/E ratio of 27.9× is below its own 5-year average of 129.9× and above the sector median of 25.0×. That places the current reading at the 5th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is AstraZeneca's historical P/E ratio range?

Accepted Answer

In the available daily series, AstraZeneca (AZN) P/E ratio has ranged from a low of 5.9× in 2011 to a high of 1880.0× in 2022. The 5-year average is 129.9× and the 5-year median is 35.8×.

Question 7

What was AstraZeneca's P/E ratio in 2025?

Accepted Answer

AstraZeneca (AZN) P/E ratio at the end of 2025 was 26.6×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month earnings figure available at that date.

Question 8

Why does AstraZeneca's P/E ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (earnings). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$272.02B	$10.22B	26.6×	-2.0×	Dec 31, 2025
2024	$201.50B	$7.04B	28.6×	-5.9×	Dec 31, 2024
2023	$205.72B	$5.96B	34.5×	-29.6×	Dec 31, 2023
2022	$211.00B	$3.29B	64.2×	-1536.0×	Dec 31, 2022
2021	$179.22B	$112.00M	1600.2×	+1558.7×	Dec 31, 2021
2020	$132.51B	$3.20B	41.5×	-57.8×	Dec 31, 2020
2019	$132.51B	$1.33B	99.3×	+54.6×	Dec 31, 2019
2018	$96.24B	$2.15B	44.7×	+15.7×	Dec 31, 2018
2017	$86.83B	$3.00B	28.9×	+9.5×	Dec 31, 2017
2016	$68.15B	$3.50B	19.5×	-10.8×	Dec 31, 2016
2015	$85.51B	$2.83B	30.3×	-41.8×	Dec 31, 2015
2014	$88.89B	$1.23B	72.1×	+43.2×	Dec 31, 2014
2013	$73.80B	$2.56B	28.9×	+19.5×	Dec 31, 2013
2012	$58.90B	$6.25B	9.4×	+3.3×	Dec 31, 2012
2011	$60.73B	$9.98B	6.1×	-2.0×	Dec 31, 2011
2010	$65.45B	$8.05B	8.1×	-0.9×	Dec 31, 2010
2009	$67.97B	$7.52B	9.0×	-0.7×	Dec 31, 2009
2008	$59.37B	$6.10B	9.7×	-1.4×	Dec 31, 2008
2007	$62.39B	$5.59B	11.2×	-2.3×	Dec 31, 2007
2006	$81.31B	$6.04B	13.5×	-2.8×	Dec 31, 2006
2005	$76.74B	$4.71B	16.3×	+0.5×	Dec 31, 2005
2004	$60.23B	$3.81B	15.8×	-10.6×	Dec 31, 2004
2003	$80.18B	$3.04B	26.4×	+5.1×	Dec 31, 2003
2002	$60.25B	$2.83B	21.3×	+1.7×	Dec 31, 2002
2001	$81.36B	$4.15B	19.6×	—	Dec 31, 2001


Medtronic (MDT)	22.2×
McKesson (MCK)	22.2×
Illumina (ILMN)	21.7×
ResMed (RMD)	21.6×
GE HealthCare (GEHC)	21.6×
Pfizer (PFE)	21.1×
Quest Diagnostics (DGX)	21.1×
Henry Schein (HSIC)	21.0×
AptarGroup (ATR)	20.9×
IQVIA (IQV)	20.7×
UnitedHealth Group (UNH)	20.4×
Biogen (BIIB)	19.7×
Zoetis (ZTS)	18.9×
Gilead Sciences (GILD)	18.8×
Humana (HUM)	18.5×
Regeneron Pharmaceuticals (REGN)	18.2×
Bristol-Myers Squibb (BMY)	17.0×
HCA Healthcare (HCA)	15.8×
DaVita (DVA)	13.3×
Incyte (INCY)	13.1×
Elevance Health (ELV)	12.3×
Cigna (CI)	11.1×
Novo Nordisk (NVO)	8.6×
Solventum (SOLV)	7.9×
Universal Health Services (UHS)	7.2×

P/E Ratio for AstraZeneca (AZN)

P/E Ratio daily chart for AstraZeneca (AZN)

Historical P/E Ratio for AstraZeneca (AZN) from 2001 to 2025

About P/E Ratio at AstraZeneca (AZN)

AstraZeneca P/E Ratio by Year

AstraZeneca P/E Ratio 2025: 26.6×

AstraZeneca P/E Ratio 2024: 28.6×

AstraZeneca P/E Ratio 2023: 34.5×

AstraZeneca P/E Ratio 2022: 64.2×

AstraZeneca P/E Ratio 2021: 1600.2×

Sector peers by P/E Ratio — chart

Sector peers by P/E Ratio — table

Frequently asked questions

AstraZeneca (AZN) Key Financials

P/E Ratio daily chart for AstraZeneca (AZN)

Historical P/E Ratio for AstraZeneca (AZN) from 2001 to 2025

About P/E Ratio at AstraZeneca (AZN)

AstraZeneca P/E Ratio by Year

AstraZeneca P/E Ratio 2025: 26.6×

AstraZeneca P/E Ratio 2024: 28.6×

AstraZeneca P/E Ratio 2023: 34.5×

AstraZeneca P/E Ratio 2022: 64.2×

AstraZeneca P/E Ratio 2021: 1600.2×

Sector peers by P/E Ratio — chart

Sector peers by P/E Ratio — table

Frequently asked questions

+What is AstraZeneca's P/E ratio?

+How is the P/E ratio calculated?

+What is the P/E ratio?

+What is a good P/E ratio for AstraZeneca?

+Is AstraZeneca's P/E ratio high or low?

+What is AstraZeneca's historical P/E ratio range?

+What was AstraZeneca's P/E ratio in 2025?

+Why does AstraZeneca's P/E ratio change over time?

AstraZeneca (AZN) Key Financials